Qureight
End-to-end imaging company for clinical trials with a focus on lung and heart disease.
$20MSeries B
Role not disclosedActivity from announced rounds
End-to-end imaging company for clinical trials with a focus on lung and heart disease.
Provides identity verification, compliance and payment infrastructure for regulated UK businesses
Predictive creative testing for brands and agencies.